ACRS Aclaris Therapeutics, Inc. - Common Stock
$6.24
가격 · 8월 25, 2026
기준 재무 정보 8월 6, 2026
52주 범위
$2–$7
94% of range
애널리스트 평점
STRONG BUY
18 analysts
목표 주가
$10
+63% upside
P/E (TTM)
-11.8
ROE
-55.3%
순이익률
-829.6%
ACRS 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$6.24
시가총액
$752M
P/E (TTM)
-11.8
EPS (TTM)
$-0.53
매출 (TTM)
$8M
배당 수익률
—
ROE
-55.3%
부채/자본
—
52주 범위
$2 – $7
ACRS 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$8M
2017-12-31
→
2025-12-31
EPS
$-0.53
2019-12-31
→
2025-12-31
잉여현금흐름
$-47M
2016-12-31
→
2025-12-31
마진
-829.6%
2017-12-31
→
2018-12-31
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
ACRS
동종업계 중앙값
P/E (TTM)
-11.8
11.7
P/S (TTM)
96.1
5.4
P/B
7.3
3.2
Price / FCF (주가 / FCF)
-15.9
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
ACRS
동종업계 중앙값
Operating Margin (영업이익률)
-975.9%
—
Net Profit Margin (순이익률)
-829.6%
-33.0%
ROA
-34.1%
-25.6%
ROE
-55.3%
-21.8%
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
ACRS
동종업계 중앙값
Current Ratio (유동비율)
3.4
4.1
Quick Ratio (당좌 비율)
0.7
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
ACRS
동종업계 중앙값
Revenue YoY (매출 YoY)
-58.2%
—
Revenue CAGR 3Y (매출 CAGR 3년)
-35.9%
—
Revenue CAGR 5Y (매출 CAGR 5년)
3.8%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
ACRS
동종업계 중앙값
ACRS 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
18 명의 애널리스트
- 적극 매수 8 44.4%
- 매수 8 44.4%
- 보유 2 11.1%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
10 명의 애널리스트 · 2026-08-23
중앙값
$10.00
지금
$6.24
저가
$4.00
고가
$16.00
중앙값 목표
$10.00
+60.3%
평균 목표
$10.20
+63.5%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
0.01%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-0.15 | $-0.16 | 0.01% |
| 2026년 3월 31일 | $-0.15 | $-0.16 | 0.01% |
| 2025년 12월 31일 | $-0.16 | $-0.15 | -0.01% |
| 2025년 9월 30일 | $-0.12 | $-0.14 | 0.02% |
| 2025년 6월 30일 | $-0.13 | $-0.14 | 0.01% |
| 2025년 3월 31일 | $-0.12 | $-0.12 | -0.00% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | — |
| YARW | — | — | — | — | — | — |
| LXRX | $421M | -8.2 | 60.2% | -101.1% | -39.7% | — |
| PCRX | $1.06B | 161.8 | 3.6% | 0.97% | 0.97% | — |
| AMPH | $1.22B | 13.2 | -1.7% | 13.6% | 12.7% | 49.5% |
| SGP | — | — | — | — | 50.0% | — |
| COLL | $1.47B | 26.8 | 23.6% | 8.1% | 23.5% | 59.4% |
| PHAT | $1.18B | -5.5 | 216.9% | -126.4% | 52.4% | 87.1% |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 17
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8M | $19M | $31M | $30M | $7M | $6M | $4M | $6M | $2M | |
| Cost of Revenue | $2M | $3M | $3M | $4M | $5M | $5M | $4M | $4M | $1M | |
| Gross Profit | · | · | · | · | · | · | · | $3M | $476.0K | |
| R&D Expense | $53M | $34M | $98M | $78M | $44M | $29M | $64M | $61M | $36M | |
| SG&A Expense | $22M | $22M | $32M | $25M | $24M | $21M | $28M | $26M | $19M | |
| Operating Expenses | $84M | $161M | $129M | $120M | $96M | $57M | $115M | $91M | $56M | |
| Operating Income | $-76M | $-142M | $-97M | $-90M | $-90M | $-51M | $-111M | $-85M | $-54M | |
| Interest Income | $8M | $8M | $9M | · | · | · | · | · | · | |
| Other Non-op | $11M | $10M | $9M | $3M | $-1M | $-424.0K | $-2M | $3M | $2M | |
| Pretax Income | $-65M | $-132M | $-89M | $-87M | $-91M | $-51M | $-114M | $-82M | $-70M | |
| Income Tax | · | · | $-367.0K | · | · | $-182.0K | · | · | $-2M | |
| Net Income | $-65M | $-132M | $-88M | $-87M | $-91M | $-51M | $-161M | $-133M | $-69M | |
| EPS (Basic) | $-0.53 | $-1.71 | $-1.27 | $-1.33 | $-1.60 | $-1.20 | $-3.90 | · | · | |
| EPS (Diluted) | $-0.53 | $-1.71 | $-1.27 | $-1.33 | $-1.60 | $-1.20 | $-3.90 | · | · | |
| Shares (Basic) | 122,564,741 | 77,296,665 | 69,808,855 | 65,213,944 | 56,730,583 | 42,539,293 | 41,323,921 | · | · | |
| Shares (Diluted) | 122,564,741 | 77,296,665 | 69,808,855 | 65,213,944 | 56,730,583 | 42,539,293 | 41,323,921 | · | · | |
| EBITDA | $-76M | $-141M | $-96M | $-89M | $-89M | $-50M | $-105M | $-134M | $-72M |
대차대조표 27
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $25M | $40M | $45M | $27M | $22M | $34M | $168M | $20M | |
| Receivables | · | $318.0K | $298.0K | $484.0K | $623.0K | $772.0K | $704.0K | $563.0K | $481.0K | |
| Inventory | · | · | · | · | · | · | $0 | $791.0K | · | |
| Prepaid Expense | · | $12M | $9M | $13M | $13M | $3M | $3M | $5M | $6M | |
| Current Assets | $96M | $126M | $129M | $232M | $205M | $57M | $84M | $179M | $200M | |
| PP&E (Net) | $761.0K | $1M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | · | $6M | $6M | $5M | $5M | $4M | $5M | $4M | $3M | |
| Accum. Depreciation | · | $5M | $4M | $4M | $3M | $3M | $2M | $1M | $480.0K | |
| Goodwill | · | · | · | · | · | · | · | $19M | $19M | |
| Intangibles | · | · | $269.0K | $7M | $7M | $7M | $7M | $7M | $7M | |
| Other Non-current Assets | $3M | $3M | $4M | $3M | $4M | $5M | $5M | $332.0K | $279.0K | |
| Total Assets | $160M | $220M | $197M | $255M | $251M | $71M | $98M | $276M | $244M | |
| Accounts Payable | $13M | $5M | $9M | $10M | $10M | $5M | $10M | $12M | $8M | |
| Accrued Liabilities | $9M | $20M | $19M | $9M | $10M | $6M | $8M | $8M | $5M | |
| Current Liabilities | $29M | $32M | $31M | $22M | $23M | $15M | $22M | $27M | $13M | |
| Capital Leases | $2M | $2M | $3M | $2M | $2M | $3M | $4M | · | · | |
| Deferred Tax | · | · | · | $367.0K | $367.0K | $367.0K | $549.0K | $549.0K | $549.0K | |
| Other Non-current Liabilities | $2M | $4M | $3M | $2M | $2M | $3M | $4M | $476.0K | $558.0K | |
| Total Liabilities | $57M | $65M | $40M | $57M | $54M | $33M | $28M | $60M | $18M | |
| Long-term Debt | · | · | · | · | · | $11M | · | $30M | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | · | · | · | |
| Paid-in Capital | $1.07B | $1.06B | $928M | $881M | $793M | $542M | $524M | $507M | $385M | |
| Retained Earnings | $-968M | $-903M | $-771M | $-682M | $-595M | $-505M | $-454M | $-292M | $-159M | |
| AOCI | $610.0K | $97.0K | $-106.0K | $-897.0K | $-224.0K | $-94.0K | $-66.0K | $-69.0K | $-246.0K | |
| Stockholders' Equity | $103M | $156M | $157M | $198M | $197M | $38M | $70M | $215M | $225M | |
| Liabilities + Equity | $160M | $220M | $197M | $255M | $251M | $71M | $98M | $276M | $244M | |
| Shares Outstanding | 120,499,433 | 107,850,124 | 70,894,889 | 66,688,647 | 61,228,446 | 45,109,314 | 41,485,638 | 41,210,725 | 30,856,505 |
현금 흐름 11
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $454.0K | $807.0K | $863.0K | $797.0K | $923.0K | $1M | $6M | $2M | $402.0K | |
| Stock-based Comp | $12M | $11M | $21M | $15M | $14M | $11M | $16M | $20M | $14M | |
| Amort. of Intangibles | · | · | $75.0K | $75.0K | $75.0K | $75.0K | $75.0K | $75.0K | $31.0K | |
| Restructuring | · | · | $3M | · | · | · | · | · | · | |
| Other Non-cash | $5M | $100M | $-11M | $4M | $24M | $-149.0K | $42M | $10M | $-972.0K | |
| Operating Cash Flow | $-47M | $-20M | $-78M | $-68M | $-52M | $-39M | $-96M | $-101M | $-55M | |
| CapEx | $111.0K | $121.0K | $1M | $605.0K | $308.0K | $453.0K | $2M | $1M | $1M | |
| Investing Cash Flow | $48M | $-70M | $46M | $13M | $-168M | $6M | $106M | $9M | $-56M | |
| Financing Cash Flow | $-6M | $75M | $27M | $73M | $225M | $18M | $-30M | $128M | $100M | |
| Net Change in Cash | $-5M | $-15M | $-5M | $18M | $5M | $-14M | $-21M | $37M | $-10M | |
| Free Cash Flow | $-47M | $-20M | $-80M | $-68M | $-52M | $-39M | $-98M | $-102M | $-56M |
수익성 8
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 32.1% | 28.3% | |
| Operating Margin | -975.9% | -758.2% | -311.6% | -302.0% | -1327.1% | -785.4% | -2627.3% | -1341.9% | -4303.2% | |
| Net Margin | -829.6% | -705.5% | -283.2% | -292.1% | -1344.0% | -787.0% | -3817.2% | -1315.4% | -4071.5% | |
| Pretax Margin | -829.6% | -705.5% | -284.3% | -292.1% | -1344.0% | -792.0% | -3817.2% | -1315.4% | -4180.2% | |
| EBITDA Margin | -970.1% | -753.9% | -308.8% | -299.3% | -1313.4% | -765.0% | -2475.7% | -1323.3% | -4279.3% | |
| ROA | -34.1% | -63.2% | -39.1% | -34.4% | -56.4% | -60.3% | -86.3% | -51.1% | -32.7% | |
| ROE | -55.3% | -92.5% | -56.5% | -41.6% | -43.9% | -130.1% | -207.9% | -73.5% | -34.7% | |
| ROIC | · | · | -61.7% | · | · | -134.8% | · | · | -31.3% |
유동성 및 지급능력 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 4.0 | 4.2 | 10.6 | 8.9 | 3.9 | 3.7 | 6.6 | 15.7 | |
| Quick Ratio | 0.7 | 0.8 | 1.3 | 2.1 | 1.2 | 1.5 | 3.4 | 6.3 | 1.6 |
효율성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | 10.3 | 17.3 | · | |
| Receivables Turnover | · | 60.8 | 79.9 | 53.8 | 9.7 | 8.8 | 6.7 | 3.8 | 7.0 |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -58.2% | -40.1% | 5.0% | 340.1% | 4.3% | · | · | · | · | |
| Revenue CAGR 3Y | -35.9% | 40.4% | 68.9% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.8% | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $19M | $31M | $30M | $7M | $6M | $4M | $6M | $2M | |
| Net Income TTM | $-65M | $-132M | $-88M | $-87M | $-91M | $-51M | $-161M | $-133M | $-69M | |
| Market Cap | $363M | $267M | $74M | $1.05B | $890M | $292M | $78M | $305M | $760M | |
| P/E | -5.7 | -1.5 | -0.8 | -11.8 | -9.1 | -5.4 | -0.5 | · | · | |
| P/S | 46.3 | 14.3 | 2.4 | 35.3 | 131.7 | 45.0 | 18.5 | 49.5 | 451.8 | |
| P/B | 3.5 | 1.7 | 0.5 | 5.3 | 4.5 | 7.8 | 1.1 | 1.4 | 3.4 | |
| P / Tangible Book | 3.5 | 1.7 | 0.5 | 5.5 | 4.7 | 9.6 | · | · | · | |
| P / Cash Flow | -7.7 | -13.3 | -1.0 | -15.5 | -17.1 | -7.6 | -0.8 | -3.0 | -13.9 | |
| P / FCF | -7.7 | -13.2 | -0.9 | -15.4 | -17.0 | -7.5 | -0.8 | -3.0 | -13.6 | |
| Earnings Yield | -17.6% | -69.0% | -121.0% | -8.4% | -11.0% | -18.6% | -206.3% | · | · |
손익계산서 15
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $1M | $3M | $2M | $1M | $9M | $4M | $3M | $2M | $18M | $9M | $2M | $3M | $8M | $19M | |
| Cost of Revenue | $218.0K | $395.0K | $532.0K | $538.0K | $515.0K | $506.0K | $705.0K | $654.0K | $624.0K | $809.0K | $725.0K | $848.0K | $1M | $808.0K | $877.0K | $923.0K | |
| R&D Expense | $18M | $16M | $17M | $13M | $11M | $12M | $9M | $6M | $9M | $10M | $27M | $24M | $25M | $23M | $21M | $24M | |
| SG&A Expense | $6M | $7M | $6M | $5M | $5M | $6M | $5M | $6M | $5M | $7M | $8M | $7M | $8M | $9M | $7M | $6M | |
| Operating Expenses | $26M | $24M | $24M | $20M | $20M | $20M | $109M | $15M | $16M | $21M | $22M | $41M | $34M | $32M | $37M | $40M | |
| Operating Income | $-24M | $-22M | $-23M | $-17M | $-18M | $-18M | $-100M | $-10M | $-13M | $-19M | $-4M | $-32M | $-32M | $-30M | $-29M | $-21M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | · | · | |
| Other Non-op | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $922.0K | |
| Pretax Income | · | · | $-20M | $-15M | $-15M | $-15M | $-97M | $-8M | $-11M | $-17M | · | · | · | · | · | · | |
| Net Income | $-22M | $-20M | $-20M | $-15M | $-15M | $-15M | $-97M | $-8M | $-11M | $-17M | $-1M | $-29M | $-30M | $-28M | $-28M | $-20M | |
| EPS (Basic) | $-0.15 | $-0.15 | $-0.16 | $-0.12 | $-0.13 | $-0.12 | $-1.21 | $-0.11 | $-0.15 | $-0.24 | $-0.02 | $-0.41 | $-0.42 | $-0.42 | $-0.41 | $-0.30 | |
| EPS (Diluted) | $-0.15 | $-0.15 | $-0.16 | $-0.12 | $-0.13 | $-0.12 | $-1.21 | $-0.11 | $-0.15 | $-0.24 | $-0.02 | $-0.41 | $-0.42 | $-0.42 | $-0.41 | $-0.30 | |
| Shares (Basic) | 142,736,848 | 128,810,050 | -245,025,840 | 122,619,311 | 122,580,967 | 122,390,303 | -136,451,324 | 71,381,731 | 71,291,400 | 71,074,858 | -138,505,385 | 70,807,934 | 70,633,528 | 66,872,778 | -128,882,450 | 66,675,337 | |
| Shares (Diluted) | 142,736,848 | 128,810,050 | -245,025,840 | 122,619,311 | 122,580,967 | 122,390,303 | -136,451,324 | 71,381,731 | 71,291,400 | 71,074,858 | -138,505,385 | 70,807,934 | 70,633,528 | 66,872,778 | -128,882,450 | 66,675,337 | |
| EBITDA | $-24M | $-22M | · | $-17M | $-18M | $-18M | · | $-10M | $-13M | $-19M | · | $-32M | $-32M | $-30M | · | $-21M |
대차대조표 24
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $29M | $20M | $25M | $25M | $30M | $25M | $48M | $23M | $36M | $40M | $39M | $31M | $45M | $45M | $62M | |
| Receivables | · | · | · | · | $194.0K | $250.0K | · | $343.0K | $325.0K | $373.0K | $298.0K | $346.0K | $431.0K | $686.0K | $484.0K | $597.0K | |
| Prepaid Expense | · | · | · | · | $4M | $3M | · | $4M | $6M | $7M | $9M | $20M | $13M | $13M | $13M | $8M | |
| Current Assets | $98M | $110M | $96M | $101M | $104M | $109M | $126M | $132M | $118M | $135M | $129M | $123M | $133M | $184M | $232M | $257M | |
| PP&E (Net) | $664.0K | $750.0K | $761.0K | $811.0K | $868.0K | $942.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| PP&E (Gross) | · | · | · | $6M | $6M | $6M | · | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | |
| Accum. Depreciation | · | · | · | $5M | $5M | $5M | · | $5M | $5M | $4M | $4M | $5M | $4M | $4M | $4M | $4M | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | $7M | $7M | $7M | $7M | $7M | |
| Other Non-current Assets | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Total Assets | $180M | $199M | $160M | $176M | $189M | $198M | $220M | $182M | $161M | $174M | $197M | $218M | $236M | $230M | $255M | $268M | |
| Accounts Payable | $16M | $15M | $13M | $9M | $9M | $6M | $5M | $8M | $7M | $11M | $9M | $10M | $11M | $8M | $10M | $8M | |
| Accrued Liabilities | $6M | $6M | $9M | $10M | $11M | $9M | $20M | $5M | $6M | $7M | $19M | $15M | $9M | $7M | $9M | $9M | |
| Current Liabilities | $28M | $27M | $29M | $26M | $27M | $22M | $32M | $19M | $16M | $20M | $31M | $27M | $23M | $18M | $22M | $20M | |
| Capital Leases | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $367.0K | $367.0K | $367.0K | $367.0K | $367.0K | |
| Other Non-current Liabilities | $1M | $1M | $2M | $2M | $2M | $4M | $4M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Total Liabilities | $55M | $55M | $57M | $55M | $57M | $54M | $65M | $52M | $27M | $32M | $40M | $62M | $56M | $53M | $57M | $48M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Paid-in Capital | $1.13B | $1.13B | $1.07B | $1.07B | $1.06B | $1.06B | $1.06B | $936M | $933M | $930M | $928M | $927M | $921M | $888M | $881M | $876M | |
| Retained Earnings | $-1.01B | $-988M | $-968M | $-948M | $-933M | $-918M | $-903M | $-806M | $-799M | $-788M | $-771M | $-769M | $-740M | $-710M | $-682M | $-655M | |
| AOCI | $-304.0K | $22.0K | $610.0K | $597.0K | $482.0K | $434.0K | $97.0K | $427.0K | $-463.0K | $-364.0K | $-106.0K | $-1M | $-1M | $-354.0K | $-897.0K | $-1M | |
| Stockholders' Equity | $125M | $144M | $103M | $120M | $132M | $144M | $156M | $130M | $134M | $142M | $157M | $156M | $180M | $177M | $198M | $220M | |
| Liabilities + Equity | $180M | $199M | $160M | $176M | $189M | $198M | $220M | $182M | $161M | $174M | $197M | $218M | $236M | $230M | $255M | $268M | |
| Shares Outstanding | 139,824,273 | 139,652,849 | 120,499,433 | 108,342,592 | 108,328,794 | 108,265,529 | 107,850,124 | 71,417,513 | 71,332,825 | 71,248,017 | 70,894,889 | 70,818,954 | 70,769,702 | 67,206,025 | 66,688,647 | 66,679,641 |
현금 흐름 11
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $107.0K | $102.0K | $102.0K | $110.0K | $114.0K | $128.0K | $143.0K | $179.0K | $242.0K | $243.0K | $228.0K | $219.0K | $218.0K | $198.0K | $190.0K | $193.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $2M | $1M | $6M | $7M | $7M | $5M | $4M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $19.0K | $19.0K | $19.0K | $18.0K | $19.0K | |
| Restructuring | · | · | · | · | · | · | · | $32.0K | $98.0K | $3M | · | · | · | · | · | · | |
| Other Non-cash | · | $-2M | · | · | · | $-2M | · | · | · | $-6M | · | · | · | $-5M | · | · | |
| Operating Cash Flow | $-20M | $-18M | $-13M | $-11M | $-10M | $-13M | $-9M | $22M | $-12M | $-21M | $-7M | $-25M | $-21M | $-26M | $-19M | $-8M | |
| CapEx | $58.0K | $13.0K | $24.0K | $23.0K | $21.0K | $43.0K | $0 | $0 | $-14.0K | $135.0K | $441.0K | $84.0K | $231.0K | $553.0K | $105.0K | $150.0K | |
| Investing Cash Flow | $10M | $-31M | $10M | $14M | $5M | $19M | $-89M | $3M | $-674.0K | $17M | $8M | $33M | $-20M | $26M | $3M | $1M | |
| Financing Cash Flow | $91.0K | $58M | $-3M | $-3M | $-9.0K | $-275.0K | $75M | $22.0K | $-11.0K | $-55.0K | $49.0K | $-87.0K | · | · | $37.0K | $-11.0K | |
| Net Change in Cash | $-9M | $9M | $-5M | $-146.0K | $-5M | $6M | $-23M | $25M | $-13M | $-4M | $838.0K | $8M | $-14M | $-555.0K | $-16M | $-7M | |
| Free Cash Flow | · | $-18M | · | · | · | $-13M | · | · | · | $-21M | · | · | · | $-27M | · | · |
수익성 6
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1487.9% | -1111.8% | · | -519.8% | -1035.9% | -1242.9% | · | -240.9% | -464.7% | -789.4% | · | -340.2% | -1702.2% | -1183.5% | · | -109.8% | |
| Net Margin | -1320.1% | -993.2% | · | -443.0% | -868.3% | -1036.8% | · | -174.6% | -397.2% | -706.5% | · | -315.2% | -1582.1% | -1113.9% | · | -104.9% | |
| Pretax Margin | · | · | · | -443.0% | -868.3% | -1036.8% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1487.9% | -1106.7% | · | -519.8% | -1035.9% | -1234.1% | · | -240.9% | -464.7% | -779.3% | · | -340.2% | -1702.2% | -1175.6% | · | -109.8% | |
| ROA | -11.7% | -10.0% | · | -8.2% | -8.8% | -8.1% | · | -3.8% | -5.5% | -8.4% | · | -12.0% | -11.5% | -12.3% | · | -7.5% | |
| ROE | -16.8% | -13.8% | · | -11.7% | -11.6% | -10.5% | · | -5.3% | -7.0% | -10.6% | · | -15.6% | -14.2% | -15.8% | · | -9.1% |
유동성 및 지급능력 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 4.0 | · | 3.9 | 3.9 | 5.1 | · | 7.0 | 7.5 | 6.7 | · | 4.5 | 5.8 | 10.1 | · | 13.0 | |
| Quick Ratio | 0.7 | 1.0 | · | 1.0 | 1.0 | 1.4 | · | 2.6 | 1.5 | 1.8 | · | 1.4 | 1.4 | 2.5 | · | 3.1 |
효율성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | · | · | · | · | 6.8 | 4.7 | · | 12.6 | 7.3 | 4.5 | · | 19.7 | 3.5 | 3.8 | · | 27.0 |
가치 평가 (TTM) 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9M | $9M | · | $11M | $10M | $11M | · | $19M | $16M | $16M | · | $33M | $25M | $25M | · | $24M | |
| Net Income TTM | $-71M | $-65M | · | $-53M | $-49M | $-51M | · | $-65M | $-87M | $-104M | · | $-107M | $-98M | $-87M | · | $-80M | |
| Market Cap | $740M | $524M | · | $206M | $154M | $166M | · | $82M | $78M | $88M | · | $485M | $734M | $544M | · | $1.05B | |
| P/E | -9.6 | -7.2 | · | -4.0 | -2.8 | -2.5 | · | -1.3 | -0.9 | -0.8 | · | -4.4 | -7.2 | -6.0 | · | -12.4 | |
| P/S | 85.0 | 61.4 | · | 18.9 | 14.9 | 15.1 | · | 4.4 | 4.8 | 5.5 | · | 14.8 | 29.4 | 22.2 | · | 44.4 | |
| P/B | 5.9 | 3.6 | · | 1.7 | 1.2 | 1.1 | · | 0.6 | 0.6 | 0.6 | · | 3.1 | 4.1 | 3.1 | · | 4.8 | |
| P / Tangible Book | 5.9 | 3.6 | · | 1.7 | 1.2 | 1.1 | · | 0.6 | 0.6 | 0.6 | · | 3.2 | 4.2 | 3.2 | · | 4.9 | |
| P / Cash Flow | · | -28.9 | · | · | · | -12.7 | · | · | · | -4.2 | · | · | · | -20.6 | · | · | |
| P / FCF | · | -28.8 | · | · | · | -12.6 | · | · | · | -4.2 | · | · | · | -20.2 | · | · | |
| Earnings Yield | -10.4% | -13.9% | · | -25.3% | -35.9% | -40.5% | · | -79.1% | -110.9% | -120.2% | · | -22.6% | -14.0% | -16.6% | · | -8.1% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $8M | $19M | $31M | $30M | $7M |
| 영업이익률 % | -975.9% | -758.2% | -311.6% | -302.0% | -1327.1% |
| 순이익 | $-65M | $-132M | $-88M | $-87M | $-91M |
| 희석 EPS | $-0.53 | $-1.71 | $-1.27 | $-1.33 | $-1.60 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 3.4 | 4.0 | 4.2 | 10.6 | 8.9 |
| 당좌 비율 | 0.7 | 0.8 | 1.3 | 2.1 | 1.2 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-47M | $-20M | $-80M | $-68M | $-52M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 160개의 제출자 · $533.8M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 30 (-6 이전 분기 대비) | 14 (0 이전 분기 대비) | 64 (+25 이전 분기 대비) | 36 (-3 이전 분기 대비) | +8.8M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $67,304,808 | 12,723,026 | 12.61% | 주식 |
| BML Capital Management, LLC | $63,347,750 | 11,975,000 | 11.87% | 주식 |
| Deep Track Capital, LP | $49,435,050 | 9,345,000 | 9.26% | 주식 |
| Vivo Capital, LLC | $35,414,630 | 6,694,637 | 6.63% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $30,776,511 | 5,817,866 | 5.77% | 주식 |
| Frazier Life Sciences Management, L.P. | $26,055,228 | 4,925,374 | 4.88% | 주식 |
| Rock Springs Capital Management LP | $22,908,514 | 4,330,532 | 4.29% | 주식 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $21,535,590 | 4,071,000 | 4.03% | 주식 |
| Decheng Capital LLC | $21,380,783 | 4,041,736 | 4.01% | 주식 |
| STATE STREET CORP | $17,220,749 | 3,255,340 | 3.23% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $14,410,007 | 2,723,241 | 2.70% | 주식 |
| BRAIDWELL LP | $11,333,021 | 2,142,348 | 2.12% | 주식 |
| Balyasny Asset Management L.P. | $10,704,156 | 2,023,470 | 2.01% | 주식 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $10,296,890 | 1,946,482 | 1.93% | 주식 |
| Kalehua Capital Management LLC | $9,693,211 | 1,832,365 | 1.82% | 주식 |
| Jones Hill Capital LP | $9,307,713 | 1,759,492 | 1.74% | 주식 |
| Palo Alto Investors LP | $8,535,045 | 1,613,430 | 1.60% | 주식 |
| Woodline Partners LP | $8,522,476 | 1,611,054 | 1.60% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7,753,738 | 1,465,735 | 1.45% | 주식 |
| PANAGORA ASSET MANAGEMENT INC | $7,174,044 | 1,356,152 | 1.34% | 주식 |
| Connor, Clark & Lunn Investment Management Ltd. | $6,400,297 | 1,209,886 | 1.20% | 주식 |
| MPM BIOIMPACT LLC | $5,514,650 | 1,042,467 | 1.03% | 주식 |
| Aldebaran Capital, LLC | $4,955,307 | 936,731 | 0.93% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $4,798,945 | 907,173 | 0.90% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $4,324,739 | 817,531 | 0.81% | 주식 |
| Three Bridge Wealth Advisors, LLC | $3,781,414 | 714,823 | 0.71% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $2,771,405 | 523,895 | 0.52% | 주식 |
| CITADEL ADVISORS LLC | $2,756,090 | 521,000 | 0.52% | 콜 옵션 |
| Aisling Capital Management LP | $2,298,267 | 434,455 | 0.43% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $2,263,078 | 427,803 | 0.42% | 주식 |
| ORBIMED ADVISORS LLC | $2,229,735 | 421,500 | 0.42% | 주식 |
| D. E. Shaw & Co., Inc. | $2,192,700 | 414,499 | 0.41% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2,182,384 | 412,549 | 0.41% | 주식 |
| Tetragon Partners GP Ltd | $2,116,000 | 400,000 | 0.40% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,830,647 | 346,058 | 0.34% | 주식 |
| GOLDMAN SACHS GROUP INC | $1,546,352 | 292,316 | 0.29% | 주식 |
| FMR LLC | $1,534,645 | 290,103 | 0.29% | 주식 |
| SUPERSTRING CAPITAL MANAGEMENT LP | $1,363,101 | 257,675 | 0.26% | 주식 |
| HighTower Advisors, LLC | $1,150,702 | 217,524 | 0.22% | 주식 |
| Logos Global Management LP | $1,058,000 | 200,000 | 0.20% | 주식 |
| CITADEL ADVISORS LLC | $997,075 | 188,483 | 0.19% | 주식 |
| Verdad Advisers, LP | $927,189 | 175,272 | 0.17% | 주식 |
| KOTLER KEVIN | $920,846 | 305,929 | 0.17% | 주식 |
| Informed Momentum Co LLC | $906,320 | 171,327 | 0.17% | 주식 |
| Assenagon Asset Management S.A. | $817,591 | 154,554 | 0.15% | 주식 |
| Atom Investors LP | $787,443 | 148,855 | 0.15% | 주식 |
| TWO SIGMA ADVISERS, LP | $768,754 | 255,400 | 0.14% | 주식 |
| RHUMBLINE ADVISERS | $757,603 | 143,216 | 0.14% | 주식 |
| ALPS ADVISORS INC | $749,852 | 141,749 | 0.14% | 주식 |
| SEI INVESTMENTS CO | $734,136 | 138,778 | 0.14% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $703,930 | 133,068 | 0.13% | 주식 |
| Vanguard Global Advisers, LLC | $682,706 | 129,056 | 0.13% | 주식 |
| Hudson Bay Capital Management LP | $634,800 | 120,000 | 0.12% | 주식 |
| CenterBook Partners LP | $625,426 | 118,228 | 0.12% | 주식 |
| CITIGROUP INC | $586,904 | 110,946 | 0.11% | 주식 |
| WELLS FARGO & COMPANY/MN | $558,857 | 105,644 | 0.10% | 주식 |
| CITADEL ADVISORS LLC | $550,160 | 104,000 | 0.10% | 풋 옵션 |
| Verition Fund Management LLC | $518,420 | 98,000 | 0.10% | 주식 |
| BlackRock, Inc. | $478,761 | 90,503 | 0.09% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $448,253 | 84,736 | 0.08% | 주식 |
| Bank of New York Mellon Corp | $430,839 | 81,444 | 0.08% | 주식 |
| STRS OHIO | $430,606 | 81,400 | 0.08% | 주식 |
| BANK OF AMERICA CORP /DE/ | $427,332 | 80,781 | 0.08% | 주식 |
| Voleon Capital Management LP | $408,219 | 77,168 | 0.08% | 주식 |
| Susquehanna Portfolio Strategies, LLC | $403,468 | 76,270 | 0.08% | 주식 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $396,851 | 75,019 | 0.07% | 주식 |
| MetLife Investment Management, LLC | $368,708 | 69,699 | 0.07% | 주식 |
| BARCLAYS PLC | $349,151 | 66,002 | 0.07% | 주식 |
| JPMORGAN CHASE & CO | $341,772 | 68,082 | 0.06% | 주식 |
| AQR CAPITAL MANAGEMENT LLC | $313,332 | 59,231 | 0.06% | 주식 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $288,718 | 54,578 | 0.05% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $280,899 | 53,100 | 0.05% | 풋 옵션 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $271,906 | 51,400 | 0.05% | 콜 옵션 |
| MANGROVE PARTNERS IM, LLC | $266,039 | 50,291 | 0.05% | 주식 |
| Invesco Ltd. | $246,905 | 46,674 | 0.05% | 주식 |
| DIVERSIFIED TRUST CO | $240,816 | 45,523 | 0.05% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $213,750 | 57,000 | 0.04% | 주식 |
| Police & Firemen's Retirement System of New Jersey | $205,390 | 38,826 | 0.04% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $187,922 | 35,524 | 0.04% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $171,428 | 32,406 | 0.03% | 주식 |
| PROFUND ADVISORS LLC | $161,271 | 30,486 | 0.03% | 주식 |
| State of Wyoming | $145,152 | 27,439 | 0.03% | 주식 |
| NEW YORK STATE COMMON RETIREMENT FUND | $144,417 | 27,300 | 0.03% | 주식 |
| Nuveen, LLC | $139,503 | 26,371 | 0.03% | 주식 |
| INTECH INVESTMENT MANAGEMENT LLC | $130,494 | 24,668 | 0.02% | 주식 |
| VOYA INVESTMENT MANAGEMENT LLC | $122,220 | 23,104 | 0.02% | 주식 |
| China Universal Asset Management Co., Ltd. | $117,586 | 22,228 | 0.02% | 주식 |
| Rafferty Asset Management, LLC | $116,364 | 21,997 | 0.02% | 주식 |
| PRUDENTIAL FINANCIAL INC | $107,228 | 20,270 | 0.02% | 주식 |
| ProShare Advisors LLC | $106,302 | 20,095 | 0.02% | 주식 |
| Verition Fund Management LLC | $105,800 | 20,000 | 0.02% | 콜 옵션 |
| VANGUARD GROUP INC | $103,661 | 34,439 | 0.02% | 주식 |
| Walleye Capital LLC | $103,557 | 19,576 | 0.02% | 주식 |
| NEUBERGER BERMAN GROUP LLC | $101,991 | 19,280 | 0.02% | 주식 |
| NORTHERN TRUST CORP | $98,463 | 18,613 | 0.02% | 주식 |
| Vontobel Holding Ltd. | $95,220 | 18,000 | 0.02% | 주식 |
| CRA Financial Services, LLC | $94,067 | 17,782 | 0.02% | 주식 |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | $85,021 | 16,072 | 0.02% | 주식 |
| Vanguard Personalized Indexing Management, LLC | $83,005 | 15,691 | 0.02% | 주식 |
| Dynamic Technology Lab Private Ltd | $72,000 | 13,521 | 0.01% | 주식 |
회사 내부자 28 명의 내부자 · 15 임원 · 14 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Neal Walker | CEO | 2025년 5월 1일 M | 1,479,824 | 0 | 0 | $0 |
| Douglas J. Manion | Pres and CEO | 2024년 1월 1일 M | 41,813 | 0 | 0 | $0 |
| Kevin Balthaser | Chief Financial Officer | 2025년 3월 1일 M | 92,608 | 0 | 0 | $0 |
| Frank Ruffo | Chief Financial Officer | 2022년 3월 10일 S | 201,883 | 0 | 0 | $0 |
| Hugh M. Davis | President and COO | 2025년 2월 3일 A | — | 0 | 0 | $0 |
| Roland Wilhelm Kolbeck | Chief Scientific Officer | 2026년 8월 1일 M | 23,990 | 0 | 0 | $0 |
| Jesse Wayne Hall | Chief Medical Officer | 2025년 5월 1일 A | — | 0 | 0 | $0 |
| Joseph Monahan | Chief Scientific Officer | 2025년 3월 1일 M | 265,662 | 0 | 0 | $0 |
| James Loerop | Chief Business Officer | 2025년 2월 3일 A | 103,306 | 0 | 0 | $0 |
| Gail Cawkwell | Chief Medical Officer | 2023년 7월 1일 M | 9,593 | 0 | 0 | $0 |
| Kamil Ali-Jackson | Chief Legal Officer | 2022년 1월 3일 M | 160,214 | 0 | 0 | $0 |
| David N. Gordon | Chief Medical Officer | 2021년 7월 13일 S | 147,447 | 0 | 0 | $0 |
| Stuart Shanler | Chief Scientific Officer | 2019년 3월 1일 A | 272,047 | 0 | 0 | $0 |
| Brett Fair | Chief Commercial Officer | 2019년 2월 1일 M | 10,582 | 0 | 0 | $0 |
| Christopher Powala | Chief Reg & Develop Officer | 2019년 2월 1일 M | 141,729 | 0 | 0 | $0 |
| Maxine Gowen | 이사 | 2026년 6월 5일 M | 33,334 | 0 | 0 | $0 |
| Vincent Milano | 이사 | 2026년 6월 5일 M | 28,896 | 0 | 0 | $0 |
| Andrew N Schiff | 이사 | 2026년 6월 5일 M | 25,540 | 0 | 0 | $0 |
| William D. Humphries | 이사 | 2026년 6월 4일 A | 45,105 | 0 | 0 | $0 |
| Christopher P. Molineaux | 이사 | 2026년 6월 4일 A | 69,536 | 0 | 0 | $0 |
| Anand Mehra | 이사 | 2026년 6월 4일 A | 726,403 | 0 | 0 | $0 |
| Bryan M. Reasons | 이사 | 2024년 6월 1일 M | 28,732 | 0 | 0 | $0 |
| Andrew Kenneth William Powell | 이사 | 2024년 6월 1일 M | 33,523 | 0 | 0 | $0 |
| Stephen A. Tullman | 이사 | 2018년 10월 4일 P | 177,457 | 0 | 0 | $0 |
| Rick Bierly | 이사 | 2017년 6월 15일 A | — | 0 | 0 | $0 |
| Albert Cha | 이사 | 2016년 6월 29일 A | 4,191,397 | 0 | 0 | $0 |
| Leonard Braden Michael | — | 2026년 4월 23일 S | 13,950,000 | 0 | 1 | $-1,359,000 |
| FMR LLC | — | 2017년 8월 21일 | — | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 4 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| M. Arkin (1999) Ltd., Moshe Arkin ×3 제출 서류 | 2019년 12월 19일 | — | 최초 제출 | — | SEC |
| Vivo Ventures VII, LLC ×6 제출 서류 | 2019년 2월 14일 | — | 최초 제출 | — | SEC |
| Sofinnova Venture Partners VIII, L.P. (“SVP VIII”), Sofinnova Management VIII, L.L.C. (“SM VIII”), Dr. Michael F. Powell (“Powell”), Dr. James I. Healy (“Healy”), Dr. Anand Mehra (“Mehra”) ×3 제출 서류 | 2018년 2월 14일 | — | 최초 제출 | 수동적 투자 | SEC |
| Vivo Ventures VII, LLC FEIN, Vivo Ventures Fund VII, L.P. FEIN, Vivo Ventures VII Affiliates Fund, L.P. FEIN | 2015년 10월 20일 | — | 최초 제출 | 수동적 투자 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 32 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.69% | 24,606 SH | 2026년 8월 21일 | 일간 |
| SBIO · ALPS ETF Trust | 0.35% | 124,304 NS | 2026년 5월 31일 | N-PORT |
| IWC · iShares Trust | 0.17% | 408,322 SH | 2026년 8월 21일 | 일간 |
| VFMO · VANGUARD WELLINGTON FUND | 0.09% | 325,402 SH | 2026년 8월 19일 | 일간 |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.06% | 8,208 SH | 2026년 8월 21일 | 일간 |
| IBB · iShares Trust | 0.05% | 818,835 SH | 2026년 8월 21일 | 일간 |
| IWO · iShares Trust | 0.04% | 960,785 SH | 2026년 8월 21일 | 일간 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.03% | 140,300 SH | 2026년 8월 21일 | 일간 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.03% | 109,271 SH | 2026년 8월 19일 | 일간 |
| BIB · ProShares Trust | 0.03% | 4,459 NS | 2026년 5월 31일 | N-PORT |
| IWM · iShares Trust | 0.02% | 3,046,668 SH | 2026년 8월 21일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.02% | 682,643 SH | 2026년 8월 19일 | 일간 |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.02% | 8,224 SH | 2026년 8월 21일 | 일간 |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.02% | 112,161 NS | 2026년 5월 31일 | N-PORT |
| RSSL · Global X Funds | 0.01% | 39,794 NS | 2026년 4월 30일 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 4,319 NS | 2026년 5월 31일 | N-PORT |
| RB · ProShares Trust | 0.01% | 27 NS | 2026년 5월 31일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 1,449,139 SH | 2026년 8월 19일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 14,250 SH | 2026년 8월 19일 | 일간 |
| VHT · VANGUARD WORLD FUND | 0.01% | 324,191 SH | 2026년 8월 19일 | 일간 |
| IWN · iShares Trust | 0.01% | 166,431 SH | 2026년 8월 21일 | 일간 |
| UWM · ProShares Trust | 0.01% | 3,377 NS | 2026년 5월 31일 | N-PORT |
| URTY · ProShares Trust | 0.00% | 3,414 NS | 2026년 5월 31일 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 92,512 NS | 2026년 4월 30일 | N-PORT |
| ITOT · iShares Trust | 0.00% | 276,461 SH | 2026년 8월 21일 | 일간 |
| HDG · ProShares Trust | 0.00% | 86 NS | 2026년 5월 31일 | N-PORT |
| IWV · iShares Trust | 0.00% | 39,494 SH | 2026년 8월 21일 | 일간 |
| DFAU · Dimensional ETF Trust | 0.00% | 26,214 NS | 2026년 4월 30일 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 404 NS | 2026년 4월 30일 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 21,533 NS | 2026년 4월 30일 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 4,243,349 SH | 2026년 8월 19일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 9,978 SH | 2026년 8월 19일 | 일간 |